Latest Advances

  • Condition: Granulomatosis with Polyangiitis (GPA) in Eyelid
  • Journal: Medicine
  • Treatment Used: Radiotherapy
  • Number of Patients: 0
  • Published —
This case report describes a 29-year-old man diagnosed with granulomatosis with polyangiitis (chronic blood vessel inflammation) occurring in the eyelid treated with radiotherapy.
  • Condition: Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Systemic Vasculitis (AAV)
  • Journal: Arthritis research & therapy
  • Treatment Used: Plasma Exchange (PE)
  • Number of Patients: 964
  • Published —
This study assessed the effectiveness of plasma exchange (removal, treatment, and return or exchange of blood plasma; PE) for patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (inflammation of small vessels; AAV).
  • Condition: Eosinophilic Granulomatosis with Polyangiitis
  • Journal: Autoimmunity reviews
  • Treatment Used: Rituximab
  • Number of Patients: 171
  • Published —
In this study, researchers evaluated the outcomes of using rituximab for the treatment of eosinophilic granulomatosis with polyangiitis.
  • Condition: Granulomatosis with Polyangiitis
  • Journal: BMJ case reports
  • Treatment Used: Avacopan
  • Number of Patients: 1
  • Published —
This study reports a case of a patient with granulomatosis with polyangiitis (GPA) who was treated with avacopan, a novel C5a receptor inhibitor, after conventional therapies were not working.
  • Condition: Anti-Neutrophilic Cytoplasmic Antibody (ANCA)-Associated Vasculitis
  • Journal: The Cochrane database of systematic reviews
  • Treatment Used: Anti-Cytokine Targeted Therapy
  • Number of Patients: 440
  • Published —
This study tested the safety and efficacy of using anti-cytokine targeted therapy to treat patients with ANCA-associated vasculitis.
  • Condition: False Positive COVID-19 Antibody Test in Patient with Granulomatosis With Polyangiitis (GPA)
  • Journal: Frontiers in medicine
  • Treatment Used: Methylprednisolone Pulses and Cyclophosphamide
  • Number of Patients: 1
  • Published —
This case report describes an 82-year-old female with granulomatosis with polyangitis (GPA) who had a false positive COVID-19 antibody test and was treated with methylprednisolone pulses and cyclophosphamide.
  • Condition: Microscopic Polyangiitis (MPA) and Granulomatosis with Polyangiitis (GPA)
  • Journal: Yonsei medical journal
  • Treatment Used: Rituximab Biosimilar
  • Number of Patients: 139
  • Published —
This study investigated the effects of rituximab on poor outcomes for microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA).
  • Condition: Peripheral Neuropathy in Eosinophilic Granulomatosis with Polyangiitis
  • Journal: Journal of immunology research
  • Treatment Used: Glucocorticoids with Immunosuppressants
  • Number of Patients: 0
  • Published —
The study researched the prevalence of peripheral neuropathy in eosinophilic granulomatosis with polyangiitis.
  • Condition: Granulomatosis with Polyangiitis (GPA)
  • Journal: PloS one
  • Treatment Used: Mycophenolic Acid and 6-Mercaptopurine
  • Number of Patients: 85
  • Published —
This study investigated whether mycophenolate-mofetil (MMF) or azathioprine (AZA) alters the circulating B-cell distribution, proliferation, and cytokine production in patients with granulomatosis with polyangiitis (small blood vessel disease; GPA).
  • Condition: ANCA-Associated Vasculitis
  • Journal: Annals of the rheumatic diseases
  • Treatment Used: Rituximab
  • Number of Patients: 188
  • Published —
In this study, researchers evaluated the outcomes of using rituximab for the treatment of relapsing ANCA-associated vasculitis.
  • Condition: Antibody-associated Vasculitis
  • Journal: Annals of internal medicine
  • Treatment Used: Rituximab
  • Number of Patients: 97
  • Published —
In this study, researchers evaluated the outcomes of using rituximab for the treatment of antibody-associated vasculitis.
Showing 1-12 of 41